Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E K Geissler

Showing results (11-20 of 44) with videos related to

Pageof 5
Sort By:
Langenbeck'S Archives of Surgery|March 7, 2008
Prolongation of heart allograft survival after long-term expression of soluble MHC class I antigens and vIL-10 in the liver by AAV-plasmid-mediated gene transferA Doenecke, E Frank, M N Scherer, et al.
The Journal of Surgical Research|July 1, 1994
Use of donor serum to prevent passive transfer of hyperacute rejectionJ Wang, E K Geissler, J H Fechner, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 15, 1994
Immunity to MHC class I antigen after direct DNA transfer into skeletal muscleE K Geissler, J Wang, J H Fechner, et al.
Current Molecular Medicine|November 24, 2015
Extracellular Citrate in Health and DiseaseM E Mycielska, V M Milenkovic, C H Wetzel, et al.
Oncogene|December 8, 2009
Rapamycin inhibits oncogenic intestinal ion channels and neoplasia in APC(Min/+) miceG E Koehl, M Spitzner, J Ousingsawat, et al.
Transplantation|April 15, 1994
Induction of specific tolerance by intrathymic injection of recipient muscle cells transfected with donor class I major histocompatibility complexS J Knechtle, J Wang, S Jiao, et al.
Human Gene Therapy|March 4, 2000
Effective use of donor MHC class I gene therapy in organ transplantation: prevention of antibody-mediated hyperacute heart allograft rejection in highly sensitized rat recipientsE K Geissler, C Graeb, S Tange, et al.
Hepatology (Baltimore, Md.)|October 26, 2000
Immunologic considerations for therapeutic strategies utilizing allogeneic hepatocytes: hepatocyte-expressed membrane-bound major histocompatibility complex class I antigen sensitizes while soluble antigen suppresses the immune response in ratsM N Scherer, C Graeb, S Tange, et al.
BJS Open|April 11, 2021
Hepatocellular carcinoma progression during bridging before liver transplantationP Renner, T Da Silva, A A Schnitzbauer, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|May 24, 2001
Local secretion of TNF-alpha from the liver does not correlate with endotoxin, IL-6, or organ function in the early phase after orthotopic liver transplantationS Tange, Y Höfer, M Welte, et al.
Pageof 5

Showing results (11-20 of 44) with videos related to

Sort By:
Pageof 5
Langenbeck'S Archives of Surgery|March 7, 2008
Prolongation of heart allograft survival after long-term expression of soluble MHC class I antigens and vIL-10 in the liver by AAV-plasmid-mediated gene transferA Doenecke, E Frank, M N Scherer, et al.
The Journal of Surgical Research|July 1, 1994
Use of donor serum to prevent passive transfer of hyperacute rejectionJ Wang, E K Geissler, J H Fechner, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 15, 1994
Immunity to MHC class I antigen after direct DNA transfer into skeletal muscleE K Geissler, J Wang, J H Fechner, et al.
Current Molecular Medicine|November 24, 2015
Extracellular Citrate in Health and DiseaseM E Mycielska, V M Milenkovic, C H Wetzel, et al.
Oncogene|December 8, 2009
Rapamycin inhibits oncogenic intestinal ion channels and neoplasia in APC(Min/+) miceG E Koehl, M Spitzner, J Ousingsawat, et al.
Transplantation|April 15, 1994
Induction of specific tolerance by intrathymic injection of recipient muscle cells transfected with donor class I major histocompatibility complexS J Knechtle, J Wang, S Jiao, et al.
Human Gene Therapy|March 4, 2000
Effective use of donor MHC class I gene therapy in organ transplantation: prevention of antibody-mediated hyperacute heart allograft rejection in highly sensitized rat recipientsE K Geissler, C Graeb, S Tange, et al.
Hepatology (Baltimore, Md.)|October 26, 2000
Immunologic considerations for therapeutic strategies utilizing allogeneic hepatocytes: hepatocyte-expressed membrane-bound major histocompatibility complex class I antigen sensitizes while soluble antigen suppresses the immune response in ratsM N Scherer, C Graeb, S Tange, et al.
BJS Open|April 11, 2021
Hepatocellular carcinoma progression during bridging before liver transplantationP Renner, T Da Silva, A A Schnitzbauer, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|May 24, 2001
Local secretion of TNF-alpha from the liver does not correlate with endotoxin, IL-6, or organ function in the early phase after orthotopic liver transplantationS Tange, Y Höfer, M Welte, et al.
Pageof 5